Emma L. Coleman

TL;DR: These results do not support these MRS devices as first-line treatment for sleepy patients with SAHS, and symptoms, treatment efficacy and satisfaction, and subjective sleepiness were also better with CPAP than with MRS.

TL;DR: It is suggested that modafinil may improve some aspects of alertness in patients with SAHS who remain sleepy during CPAP therapy, but further studies are required to assess the significance of the reduction in CPAP use.

TL;DR: Although both BIS and SEF decreased with increasing sleep depth, the distribution of values at each sleep depth was considerable, with overlap between each sleep stage, and neither BIS nor SEF reliably indicated conventionally determined sleep stages.

TL;DR: OSAH does not appear to be strongly associated with TIAs, and the primary outcome measure, the apnea/hypopnea index, was the same for cases and controls.

TL;DR: Continuance with MRS may be low and linked to tolerance problems, and continued use of MRS therapy was associated with a higher number of teeth, low marital satisfaction perceived by partners and greater improvement in symptoms reported by patients and partners.